Risks for adverse pregnancy outcomes higher for severe infection versus mild infection
MONDAY, March 22, 2021 (HealthDay News) — COVID-19 is associated with increased risks for preeclampsia, preterm birth, and other adverse pregnancy outcomes, according to a review published online March 19 in CMAJ, the journal of the Canadian Medical Association.
Shu Qin Wei, M.D., Ph.D., from the Université de Montréal, and colleagues conducted a systematic literature review and meta-analysis of data from studies (through Jan. 29, 2021) evaluating the severity of COVID-19 infection during pregnancy.
Based on 42 studies (438,548 pregnant women), the researchers found that COVID-19 was associated with preeclampsia (odds ratio [OR], 1.33), preterm birth (OR, 1.82), and stillbirth (OR, 2.11) compared with women with no severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy. Severe COVID-19 was strongly associated with preeclampsia (OR, 4.16), preterm birth (OR, 4.29), gestational diabetes (OR, 1.99), and low birth weight (OR, 1.89) compared with mild SARS-CoV-2 infection.
“Clinicians should be aware of these adverse outcomes when managing pregnancies in patients with COVID-19 and adopt effective strategies to prevent or reduce risks to patients and fetuses,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Maternal Vitamin D Status Linked to Preterm Delivery 
IBD Not Linked to Risk for Hypertensive Disorders of Pregnancy Overall 
Mom"s Poor Sleep in Late Pregnancy Linked to Offspring"s Obesity Risk in Early Childhood 
High Intake of Eggs, Peanuts in Pregnancy Does Not Lower Allergy Risk 
Altered Markers of Ovarian Development Seen With Fetal Acetaminophen Exposure 
Distinct Skin Microbiome Features Emerge Before Atopic Disease Onset in Infants .jpg)
Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy 
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects .jpg)
